BIOCRYST PHARMACEUTICALS INC Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Biocryst Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was 26.4 %, a 60.3% decline year-over-year.
  • Biocryst Pharmaceuticals Inc annual Return On Equity for 2023 was 57.2 %, a 47% decline from 2022.
  • Biocryst Pharmaceuticals Inc annual Return On Equity for 2022 was 108 %, a 36.1% decline from 2021.
  • Biocryst Pharmaceuticals Inc annual Return On Equity for 2021 was 169 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 26.4 -40.1 -60.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 32.1 -45.3 -58.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 48.2 -35.7 -42.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 57.2 -50.8 -47% Oct 1, 2023 Dec 31, 2023
Q3 2023 66.5 -39.9 -37.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 77.4 -55.4 -41.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 83.9 -64.1 -43.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 108 -61.2 -36.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 106 -155 -59.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 133 -381 -74.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 148 +5.42K Jan 1, 2022 Mar 31, 2022
Q4 2021 169 +943 Oct 1, 2021 Dec 31, 2021
Q3 2021 261 +590 Jul 1, 2021 Sep 30, 2021
Q2 2021 514 +1.12K Apr 1, 2021 Jun 30, 2021
Q1 2021 -5.27K -10.7K -198% Jan 1, 2021 Mar 31, 2021
Q4 2020 -774 +3.45K +81.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -329 +2.18K +86.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -604 -232 -62.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 5.4K +5.63K Jan 1, 2020 Mar 31, 2020
Q4 2019 -4.22K -4.05K -2302% Oct 1, 2019 Dec 31, 2019
Q3 2019 -2.51K -2.37K -1681% Jul 1, 2019 Sep 30, 2019
Q2 2019 -371 -263 -244% Apr 1, 2019 Jun 30, 2019
Q1 2019 -223 -109 -95.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 -176 -69.3 -65.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -141 -17.8 -14.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -108 +169 +61% Apr 1, 2018 Jun 30, 2018
Q1 2018 -114 +209 +64.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -107 +365 +77.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -123 +173 +58.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -277 -88.6 -47.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -324 -230 -244% Jan 1, 2017 Mar 31, 2017
Q4 2016 -472 -404 -592% Oct 1, 2016 Dec 31, 2016
Q3 2016 -296 -244 -467% Jul 1, 2016 Sep 30, 2016
Q2 2016 -188 -147 -359% Apr 1, 2016 Jun 30, 2016
Q1 2016 -94 -30 -46.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -68.2 +6.02 +8.11% Oct 1, 2015 Dec 31, 2015
Q3 2015 -52.2 +41.3 +44.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -41 +135 +76.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -64.1 -1.21K -106% Jan 1, 2015 Mar 31, 2015
Q4 2014 -74.3 -1.33K -106% Oct 1, 2014 Dec 31, 2014
Q3 2014 -93.5 -1.69K -106% Jul 1, 2014 Sep 30, 2014
Q2 2014 -176 -6.03K -103% Apr 1, 2014 Jun 30, 2014
Q1 2014 1.14K +1.82K Jan 1, 2014 Mar 31, 2014
Q4 2013 1.25K +1.58K Oct 1, 2013 Dec 31, 2013
Q3 2013 1.6K +1.86K Jul 1, 2013 Sep 30, 2013
Q2 2013 5.86K +6.09K Apr 1, 2013 Jun 30, 2013
Q1 2013 -678 -484 -250% Jan 1, 2013 Mar 31, 2013
Q4 2012 -325 Oct 1, 2012 Dec 31, 2012
Q3 2012 -260 Jul 1, 2012 Sep 30, 2012
Q2 2012 -231 Apr 1, 2012 Jun 30, 2012
Q1 2012 -194 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.